Clinical Trials Directory

Trials / Unknown

UnknownNCT02903797

Irisin Hormone Levels in Endometrial Hyperplasia

The Relation Between Serum Irisin Hormone Level and Endometrial Hyperplasia

Status
Unknown
Phase
Study type
Observational
Enrollment
80 (estimated)
Sponsor
Kayseri Education and Research Hospital · Other Government
Sex
Female
Age
35 Years – 50 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to determine serum irisin hormone levels an its relation between endometrial hyperplasia

Detailed description

The study consisted of two groups. The first group was formed of the patients diagnosed endometrial hyperplasia histopathologically , and the controls were healthy women admitted to the clinic just for annual examination without any complain and symptoms. Patients in the 35-50 age range in both groups were included in the study. The histopathologic diagnosis of patients was established for Kayseri Education and Research Hospital Pathology clinics. Demographic parameters such as age, menopausal status, body mass index (BMI), body weight and known familial cancer story were registered. Pregnancy, liver function disorders, cardiovascular disease, metabolic disease, diabetes, chronic kidney disease, central nerves system disease, immunosuppressive drug use, another known malignancy and excessive exercises in among one month were all exclusion criteria for the patients. 3 cc peripheral venous blood samples were taken in the patients' diagnosed endometrial hyperplasia in the course of evaluation the biopsy results and in controls during their examinations just for only once. Blood samples were centrifuged in 3200 rpm speed for 10 minutes, and stored in -80 'C until the analysis. Blood samples were evaluated on the same day after four mounts for stored first blood sample. Serum Irisin levels were evaluated with enzyme- linked immunosorbent assays kit (Catalog number: K4761-100 Biovision USA) in Kayseri Research and Education Hospital Biochemical Clinics.

Conditions

Timeline

Start date
2016-08-01
Primary completion
2017-01-01
Completion
2017-02-01
First posted
2016-09-16
Last updated
2016-09-16

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT02903797. Inclusion in this directory is not an endorsement.

Irisin Hormone Levels in Endometrial Hyperplasia (NCT02903797) · Clinical Trials Directory